As per the latest market research conducted by FMI, the global CBD oil market is expected to record a CAGR of 31% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of USD 389 million. By 2033, the valuation is anticipated to reach USD 5,980.6 million.
Increasing amounts of skincare products that treat acne and wrinkles contain cannabidiol oil. For instance, Sephora recently added a line of CBD-infused beauty products to its retail locations.
Similar to this, Ulta Beauty plans to introduce a range of products based on cannabidiol. Also, a number of new businesses are entering the market for cosmetics containing cannabidiol.
Owing to its therapeutic benefits, there is a significant expansion in the CBD oil capsules market for health and wellness applications, which is the main reason for driving the growth of the current market. The increased acceptability and use of products as a result of government approvals is another important factor anticipated to increase the manufacturing of CBD-infused goods.
Increasing Understanding to control Market Demand and Supply
Small and medium-sized businesses are using cannabidiol more frequently as a result of growing public awareness of its therapeutic effects. Also, hemp oil is widely used in the pharmaceutical industry since it eases physical pain, which is a good indicator. This supports the market's expansion in turn.
Market Growth was Impacted by Cosmetic Industry’s Growth and Expansion
This market is expected to expand both directly and indirectly as a result of the personal care and cosmetics industry's growth and expansion. This is due to the fact that cannabidiol is useful for treating skin disorders, including eczema and psoriasis, as well as inflammation, discomfort, and redness brought on by ongoing outbreaks.
Increasing Research and Development Operations
Increased financing from the federal government related to research and development proficiencies is also encouraging the expansion of the industry. The best and quickest use of resources is likely to be ensured through research and development activities focused on sustainable development, increasing the market value.
| Attributes | Value |
|---|---|
| CBD Oil Value (2022) | USD 373.72 million |
| CBD Oil Market Expected Value (2023) | USD 389 million |
| CBD Oil Market Forecast Value (2033) | USD 5,980.6 million |
| CBD Oil Market Expected CAGR (2023 to 2033) | 31% |
Increasing demand for CBD oil in the production of medicines owing to its pain-reducing properties has been facilitating growth in the CBD oil market over the past few years. From 2018 to 2022, the market recorded a CAGR of 11.3%.
CBD oil regulates the endocannabinoid system (ECS) activity and interacts with neurotransmitters. This property makes it an ideal ingredient for anxiety and anti-depression drugs.
In 2018, The World Anti-Doping Agency (WADA) removed cannabidiol (CBD) oil from its list of a prohibited substances. However, all synthetic cannabinoids that mimic the effects of THC are prohibited.
Backed by favorable policies, the global CBD oils market recorded a CAGR of 31.5% and surpassed sales revenue of USD 284.2 million in 2021, says FMI.
Entrepreneurs in the CBD oil industry are concentrating on creating lotions, skin care, pet care, and textile items using cannabidiol, which on the other hand, is driving the CBD oil for pets market.
Increasing market prospects are likely to be offered, particularly in emerging economies, by increasing sales of a variety of CBD-fortified products, new product launches, and the expansion of the product pipeline.
The market is expected to expand as a result of increased research and development (R&D) efforts to lower THC concentration and growing pressure to obtain regulatory approval from agencies more quickly. However, regulations imposed on the application and sales of certain items are likely to hinder sales during the predicted period.
Due to a strong network of online sales channels, widespread knowledge of the many advantages of cannabidiol, and the introduction of retail products like CBD oil, CBD gummies, and CBD beverages in these regions, Europe and North America collectively are expected to hold more than 70% of the global market share for CBD oil.
Research has demonstrated that hemp and marijuana-derived CBD oil plants have the ability to reduce anxiety and tension. When taken as a supplement, CBD oil has therapeutic advantages for neurological illnesses and conditions like depression, discomfort from the nerves, insomnia, and inflammatory pain. This has accelerated the use of CBD oil in the production of drugs used to treat anxiety and pain.
Many pharmaceutical companies are looking to integrate CBD oil into pain-relief medication and introduce new products in the market. For instance, in 2021, dosist™ introduced its progressive new range of CBD+ topical products with all-natural solutions designed to help with pain relief.
The legalization of CBD oil's medical claims has been made possible by relaxing cannabis laws and rising public knowledge of its advantages. Numerous celebrities address their sleep difficulties using CBD oil and related products. In the future years, the sales of CBD oil products are likely to be boosted by celebrity evangelists' endorsement.
Due to favorable rules governing the use of CBD products and an increasing population who are concerned about their health, the United States is predicted to dominate the CBD oil market over the projected period. The United States agricultural bill's approval in 2020 increased the sales of CBD oil.
Around 50 million persons in the United States suffer from sleep disorders, according to the American Sleep Association. CBD oil modulates and interacts with neurotransmitters, thus helping in achieving deep sleep and alleviating insomnia.
The prevalence of sleep disorders is on the rise, and more studies are showing how well CBD works to treat these conditions, which is expected to help the industry expand in the United States.
Demand for this market is being driven by the high efficacy of CBD extracted from hemp for various medicinal uses, such as creating a treatment for Parkinson's illness.
Growth is anticipated to be fueled by rising consumer awareness of the health advantages of CBD extracted from hemp oil throughout the assessment period.
The rise in healthcare spending by consumers and the legalization of medical marijuana in North America and Europe are both factors contributing to the demand for hemp oil in the pharmaceutical sector.
According to FMI, more than 50% of CBD oil sales are likely to be accomplished through online channels.ommerce retail allowed top established and new entrants in CBD oil manufacturing, marketing, and sales to reach customers all around the world.
Some CBD oil manufacturers are selling their products exclusively through e-commerce websites to reach more consumers and create a loyal customer base. However, FMI predicts that the CBD oil market might reflect a paradoxical trend. The demand might shift towards brick-and-mortar stores through 2033.
By application type, the food and beverage industry is expected to record high growth due to increasing demand for CBD gummies and snacks across the globe. Market players are working to produce new flavors and are trying to make CBD snacks more accessible to gain a competitive advantage.
FMI expects this segment to grow exponentially owing to an increasing focus on getting certification by international organizations and growing awareness regarding the health benefits of consuming CBD gummies.
The demand for CBD oil is consistently rising encouraging several newcomers to venture into the market. Consequently, competition is increasing in the market. Established companies are focusing on strategic collaborations to gain a competitive edge.
Recent Developments
Strategic partnership and collaboration are in the cards to enter potential markets of Asia and Africa. For instance, in April 2020, Australian CBD firm Creso signed an agreement with Pakistani pharmaceutical firm Highnoon laboratories to sell CBD-derived therapeutic products in Pakistan.
These key players are identified as leading market players, according to Future Market Insights. They collectively accounted for more than 15% of the global market share in 2021.
As the CBD oil market is in a nascent stage, market players are focusing on gaining maximum share by expanding their product portfolio through new product launches.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million for Value & Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, Rest of Latin America, EU-5, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Denmark, Finland, Iceland, Norway, Sweden), Poland, Russia, Rest of Europe, China, India, Japan, GCC Countries, South Africa, Israel, Türkiye, Iran, Rest of Middle East & Africa, Australia, New Zealand, South Korea, the Philippines, Malaysia, and Thailand |
| Key Segments Covered | By Product Type, By Distribution Channel, By Application, and By Region |
| Key Companies Profiled | CV Sciences; Medical Marijuana; Aurora Cannabis; Canopy Growth Corporation; Canntrust; Tilray; and Kazmira LLC |
| Report Coverage | Market Overview, Market Background, Market Forecast, Segmental Analysis, Regional Profiling and Competition Analysis |
| Customization & Pricing | Available upon Request |
The market is valued at USD 389 million in 2023.
The growth potential of the CBD oil market is 31% CAGR through 2033.
The market is estimated to reach USD 5,980.6 million by 2033.
Pharmaceutical companies are integrating CBD oil into painkiller medications, which may propel market growth.
CV Sciences, Medical Marijuana, and Aurora Cannabis are key CBD oil market players.
Explore Similar Insights
CBD Oil Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
